Table: Torii Pharmaceutical - Q1 parent results
Apr 28 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2021 Mar 31, 2020 Dec 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 9.90 9.57 45.70
(+3.4 pct) (+4.5 pct) (+9.6 pct)
Operating 689 mln 1.25 3.80
(-44.9 pct) (-19.8 pct)
Recurring 650 mln 1.32 4.10
(-50.6 pct) (-17.5 pct)
Net 436 mln 862 mln 2.70
(-49.5 pct) (-97.0 pct) (-22.8 pct)
EPS 15.53 yen 30.74 yen 96.14 yen
EPS Diluted 15.53 yen 30.73 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)